An Easy-to-Use Risk Stratification System for NSTE-ACS Patients Combining Autonomic Nervous System and Coronary Physiology.

IF 3.2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
International Journal of Medical Sciences Pub Date : 2025-04-28 eCollection Date: 2025-01-01 DOI:10.7150/ijms.111214
Xiaomeng Yang, Zeyan Li, Xinyu Liu, Tianyou Xu, Fu Yu, Shoupeng Duan, Qiang Deng, Lang Wang, Zhuo Wang, Hong Jiang, Lilei Yu
{"title":"An Easy-to-Use Risk Stratification System for NSTE-ACS Patients Combining Autonomic Nervous System and Coronary Physiology.","authors":"Xiaomeng Yang, Zeyan Li, Xinyu Liu, Tianyou Xu, Fu Yu, Shoupeng Duan, Qiang Deng, Lang Wang, Zhuo Wang, Hong Jiang, Lilei Yu","doi":"10.7150/ijms.111214","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The evaluation of autonomic nervous system (ANS) function and coronary physiology through quantitative flow ratio (QFR) analysis provides a precise method for assessing the severity and prognosis of acute coronary syndrome (ACS). <b>Aims:</b> This study aimed to develop and validate a risk score model for predicting the long-term prognosis of non-ST-elevation ACS (NSTE-ACS) patients who underwent complete and successful percutaneous coronary intervention (PCI). <b>Methods:</b> NSTE-ACS patients who underwent complete and successful PCI with preoperative and postoperative QFR measurements between January 2018 and December 2020 in our medical center were included. 24-hour Holter monitoring was performed to assess deceleration capacity (DC) and heart rate variability (HRV) parameters. The primary endpoint was the occurrence of major adverse cardiac events (MACEs). <b>Results:</b> The training cohort consisted of 271 patients, while the testing cohort consisted of 119 patients. The nomogram considered diabetes, normalized low-frequency (nLF) power/normalized high-frequency (nHF) power, DC, cardiac troponin I (cTnI), post-PCI QFR of the target vessel. The model demonstrated excellent discriminative ability, with area under the curve (AUC) values of 0.874 (95% CI: 0.809-0.939) for 1-year MACE prediction in the training cohort and 0.893 (95% CI: 0.808-0.978) in the testing cohort. For 2-year MACE prediction, the AUC values were 0.882 (95% CI: 0.822-0.942) and 0.842 (95% CI: 0.724-0.960) in the training and testing cohorts. <b>Conclusions:</b> We successfully developed and validated a risk stratification system that integrates baseline clinical characteristics (diabetes, cTnI levels), ANS parameters (nLF/nHF ratio, DC), and coronary physiological assessment (post-PCI QFR). This model effectively predicts MACEs in NSTE-ACS patients following PCI, providing valuable prognostic information for clinical decision-making.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"22 10","pages":"2342-2353"},"PeriodicalIF":3.2000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080570/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/ijms.111214","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The evaluation of autonomic nervous system (ANS) function and coronary physiology through quantitative flow ratio (QFR) analysis provides a precise method for assessing the severity and prognosis of acute coronary syndrome (ACS). Aims: This study aimed to develop and validate a risk score model for predicting the long-term prognosis of non-ST-elevation ACS (NSTE-ACS) patients who underwent complete and successful percutaneous coronary intervention (PCI). Methods: NSTE-ACS patients who underwent complete and successful PCI with preoperative and postoperative QFR measurements between January 2018 and December 2020 in our medical center were included. 24-hour Holter monitoring was performed to assess deceleration capacity (DC) and heart rate variability (HRV) parameters. The primary endpoint was the occurrence of major adverse cardiac events (MACEs). Results: The training cohort consisted of 271 patients, while the testing cohort consisted of 119 patients. The nomogram considered diabetes, normalized low-frequency (nLF) power/normalized high-frequency (nHF) power, DC, cardiac troponin I (cTnI), post-PCI QFR of the target vessel. The model demonstrated excellent discriminative ability, with area under the curve (AUC) values of 0.874 (95% CI: 0.809-0.939) for 1-year MACE prediction in the training cohort and 0.893 (95% CI: 0.808-0.978) in the testing cohort. For 2-year MACE prediction, the AUC values were 0.882 (95% CI: 0.822-0.942) and 0.842 (95% CI: 0.724-0.960) in the training and testing cohorts. Conclusions: We successfully developed and validated a risk stratification system that integrates baseline clinical characteristics (diabetes, cTnI levels), ANS parameters (nLF/nHF ratio, DC), and coronary physiological assessment (post-PCI QFR). This model effectively predicts MACEs in NSTE-ACS patients following PCI, providing valuable prognostic information for clinical decision-making.

结合自主神经系统和冠状动脉生理学的易于使用的NSTE-ACS患者风险分层系统。
背景:通过定量血流比(QFR)分析评价自主神经系统(ANS)功能和冠脉生理,为评估急性冠脉综合征(ACS)的严重程度和预后提供了一种精确的方法。目的:本研究旨在建立并验证一种风险评分模型,用于预测非st段抬高ACS (NSTE-ACS)患者接受完整且成功的经皮冠状动脉介入治疗(PCI)的长期预后。方法:纳入2018年1月至2020年12月在我们医疗中心接受完整且成功的PCI术前和术后QFR测量的NSTE-ACS患者。24小时动态心电图监测以评估减速能力(DC)和心率变异性(HRV)参数。主要终点是主要心脏不良事件(mace)的发生。结果:训练组包括271例患者,测试组包括119例患者。图考虑糖尿病、归一化低频(nLF)功率/归一化高频(nHF)功率、DC、心肌肌钙蛋白I (cTnI)、pci后靶血管QFR。该模型具有良好的判别能力,训练组预测1年MACE的曲线下面积(AUC)为0.874 (95% CI: 0.809-0.939),检验组预测1年MACE的曲线下面积(AUC)为0.893 (95% CI: 0.808-0.978)。对于2年MACE预测,训练组和测试组的AUC值分别为0.882 (95% CI: 0.822-0.942)和0.842 (95% CI: 0.724-0.960)。结论:我们成功开发并验证了一种风险分层系统,该系统整合了基线临床特征(糖尿病、cTnI水平)、ANS参数(nLF/nHF比率,DC)和冠状动脉生理评估(pci后QFR)。该模型可有效预测PCI术后NSTE-ACS患者的mace,为临床决策提供有价值的预后信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Medical Sciences
International Journal of Medical Sciences MEDICINE, GENERAL & INTERNAL-
CiteScore
7.20
自引率
0.00%
发文量
185
审稿时长
2.7 months
期刊介绍: Original research papers, reviews, and short research communications in any medical related area can be submitted to the Journal on the understanding that the work has not been published previously in whole or part and is not under consideration for publication elsewhere. Manuscripts in basic science and clinical medicine are both considered. There is no restriction on the length of research papers and reviews, although authors are encouraged to be concise. Short research communication is limited to be under 2500 words.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信